Betanidine or bethanidine

This classification denotes an adrenergic antagonist with the molecular formula C10H15N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W8S3YM7AUU, chemically known as 2-benzyl-1,3-dimethylguanidine but generally known as betanidine, which bears US NIH Compound Identifier 2368. Betanidine most often comes in base and sulfate forms. European Medicines Agency schedules Betanidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05801MIG. The term BETANIDINE is an International Non-Proprietary Name. World Health Organization schedules betanidine in its Anatomical Therapeutic Chemical (ATC) Classification. BETANIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Betanidine or bethanidine bears US NLM identifiers UMLS ID C0005324 and NCI Concept Code C81343. SMILES: CNC(=NC)NCC1=CC=CC=C1.